Home
Business
Metro
Nation
World
Sports
Feature
Opinion
View more »Opinion Columns
Wan LixinOpinion deputy editor of Shanghai Daily
Shanghai sorting out a sustainable future
Rural tourism: Success depends on more than just green fields and a nostalgic idyll
Sunday
- Subscribe
Home » Metro » Health and Science
Viral hepatitis to be controllable in future
By Cai Wenjun |
June 23, 2012, Saturday
|
Print Edition
Print Edition
VIRAL hepatitis is likely to be controllable in 20 years with the development of hepatitis vaccines and immunity medicine, medical experts told an international symposium on viral hepatitis and liver disease in Shanghai yesterday.
Viral hepatitis is the most prevalent of 28 serious infectious diseases in China with an incidence of 0.1 percent.
Over 1.37 million Chinese were diagnosed with viral hepatitis last year - 42.4 percent of all cases among the 28 serious infectious diseases. Liver cancer, mainly caused by viral hepatitis, has the second-highest mortality among all cancers.
Thanks to the promotion of hepatitis B vaccination, the incidence of hepatitis B carriers dropped from 9.75 percent in 1992 to the current 7.17 percent, which means 30 million Chinese have avoided catching the virus in the past decade, experts told the symposium, attended by some 2,500 participants from 44 countries and regions.
Research on viral hepatitis and liver cancer in China has improved greatly in recent years, experts said. More Chinese scientists have had articles published on the topic in scientific journals recently than any other country except the United States.
Dr Wang Hongyang, a medical researcher and member of the Chinese Academy of Engineering, said during the symposium that he has discovered a series of liver cancer markers for early cancer identification. He said the current cancer marker diagnosis has an accuracy rate of 40 percent, while his measure can increase the accuracy rate of early diagnosis by 15 percent points.
It has received a patent in China and is being appraised by the State Food and Drug Administration.
Viral hepatitis is the most prevalent of 28 serious infectious diseases in China with an incidence of 0.1 percent.
Over 1.37 million Chinese were diagnosed with viral hepatitis last year - 42.4 percent of all cases among the 28 serious infectious diseases. Liver cancer, mainly caused by viral hepatitis, has the second-highest mortality among all cancers.
Thanks to the promotion of hepatitis B vaccination, the incidence of hepatitis B carriers dropped from 9.75 percent in 1992 to the current 7.17 percent, which means 30 million Chinese have avoided catching the virus in the past decade, experts told the symposium, attended by some 2,500 participants from 44 countries and regions.
Research on viral hepatitis and liver cancer in China has improved greatly in recent years, experts said. More Chinese scientists have had articles published on the topic in scientific journals recently than any other country except the United States.
Dr Wang Hongyang, a medical researcher and member of the Chinese Academy of Engineering, said during the symposium that he has discovered a series of liver cancer markers for early cancer identification. He said the current cancer marker diagnosis has an accuracy rate of 40 percent, while his measure can increase the accuracy rate of early diagnosis by 15 percent points.
It has received a patent in China and is being appraised by the State Food and Drug Administration.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
